CCL5 and neoplasm: MSC pre-treated with cisplatin increased CCL5 expression and phosphorylation of tyrosine kinases (PLC, WNK1, c-Jun, STAT3), possibly playing roles in tumor cell changes, as witnessed in breast cancer cells (111).